All Stories

Agenus CMO touts immunotherapy advances on The Top Line

Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.

Mar 17, 2025 - 13:10
 0
Agenus CMO touts immunotherapy advances on The Top Line
Dr. Steven O'Day of Agenus discusses the future of cancer immunotherapy on The Top Line podcast. Learn about 'cold' tumors and a potential '2.0 revolution' in immuno-oncology.
Read More

Tags:

Previous Article

Think Roundtrip Flights Save You Money? One-Ways Offer More Flexibility—And Can ...

Next Article

Copenhagen Infrastructure Partners raises €12 billion in fifth renewables fund

Related Posts

Chutes & Ladders—Gilead's accounting chief hits the exit

Chutes & Ladders—Gilead's accounting chief hits the exit

Mar 14, 2025  0

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs; Atea reduces head count by 25%

Fierce Biotech Layoff Tracker 2025: BMS cuts 57 CA jobs...

Mar 7, 2025  0

Arcturus confident of retaining BARDA funding for bird flu trial, despite Moderna uncertainty

Arcturus confident of retaining BARDA funding for bird ...

Mar 7, 2025  0